Intra-Cellular Therapies Announces The Successful Completion Of A Phase Ib/II Study Of ITI-007 In Patients With ...

Intra-Cellular Therapies, Inc. announced the results from a Phase Ib/II clinical trial in patients with schizophrenia with ITI-007, the Company's unique, investigational new drug for the treatment of schizophrenia. The trial met its primary endpoint demonstrating that ITI-007 was safe and well-tolerated in patients with stabilized schizophrenia. In addition, several exploratory endpoints were ...

NZ ranks last in medicine use and lowest health spender

New Zealand has been ranked last in a comparison of 14 developed nations on their use of selected medicines.New Zealand was far below Australia in the study, which was done for the British Government and tallied medicine use for...

Your news

BEDFORD: Holland & Knight has announced that John Dadakis has joined the firm's New York office as a partner in the Private Wealth Services practice group.

Practice Fusion Releases Prescription Index, Launches Research Division

Practice Fusion launches its Research Division today with the release of a Prescription Index tracking medication volume by physician specialty. Â Prescriptions for blood pressure , cholesterol , infection and depression topped the four lists. Â Practice Fusion's new Research Division provides the critical information needed to power clinical research for drug interaction monitoring, disease ...

A revamped resource website from the American Cancer Society

If you're in the unwelcome position of needing as much good information as possible about cancer treatments and support, take a look at the American Cancer Society's revamped website. The society hopes the changes it has made will make the site more user-friendly and helpful.